Page last updated: 2024-08-23

tetradecanoylphorbol acetate and 6-bromoindirubin-3'-oxime

tetradecanoylphorbol acetate has been researched along with 6-bromoindirubin-3'-oxime in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Chen, CL; Chen, SH; Choi, PC; Hsieh, CY; Huang, WC; Lin, CF; Lin, YS; Tsai, CC; Tseng, PC; Wong, TW1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and 6-bromoindirubin-3'-oxime

ArticleYear
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Inhibiting glycogen synthase kinase-3 decreases 12-O-tetradecanoylphorbol-13-acetate-induced interferon-γ-mediated skin inflammation.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 343, Issue:1

    Topics: Animals; Cell Line; Dermatitis; Glycogen Synthase Kinase 3; Humans; Indoles; Interferon gamma Receptor; Interferon-gamma; Mice; Mice, Inbred C57BL; Mice, Knockout; Oximes; Receptors, Interferon; Tetradecanoylphorbol Acetate

2012